The Patent Finder

Pharmaceutical Products and Stable Liquid Compositions of IL-17 Antibodies

Novartis Pharma AG

A patent family: one line of work, grouped by real continuity rather than by a technology label inferred from titles. 7 of these applications claim priority to application PCT/IB2015/059836, filed Dec 21, 2015. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleHolderStatusExpiresPatent lifetimeUsedRemainingConfidence
US 11,801,300Pharmaceutical Products and Stable Liquid Compositions of IL-17 Antibodies
In force
 · High confidence
UsedRemaining
Novartis Pharma AGIn forceHigh confidence
US 12,296,008Pharmaceutical Products and Stable Liquid Compositions of IL-17 Antibodies
In force
 · High confidence
Novartis Pharma AGIn forceHigh confidence
US 12,485,172Pharmaceutical Products and Stable Liquid Compositions of IL-17 Antibodies
In force
 · Low confidence
Novartis Pharma AGIn forceLow confidence
US 12,485,173Pharmaceutical Products and Stable Liquid Compositions of IL-17 Antibodies
In force
 · Low confidence
Novartis Pharma AGIn forceLow confidence
US 12,544,438Pharmaceutical Products and Stable Liquid Compositions of IL-17 Antibodies
In force
 · High confidence
Novartis Pharma AGIn forceHigh confidence
US 12,702,711Pharmaceutical Products and Stable Liquid Compositions of IL-17 Antibodies
In force
 · High confidence
Novartis Pharma AGIn forceHigh confidence
US 12,741,024Pharmaceutical Products and Stable Liquid Compositions of IL-17 Antibodies
In force
 · High confidence
Novartis AGIn forceHigh confidence
US 12,599,664Pharmaceutical Products and Stable Liquid Compositions of IL-17 Antibodies
In force
 · High confidence
Novartis Pharma AGIn forceHigh confidence
Application 19/644,346Pharmaceutical Products and Stable Liquid Compositions of IL-17 Antibodies
Pending
Not granted
Novartis AGPendingNot granted
9 of 9 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
7 of these are in force and held by Novartis Pharma AG.
Updated Nov 20, 2026 · includes USPTO assignment data published Nov 19, 2026, status data published Nov 20, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 20, 2026 · includes USPTO assignment data published Nov 19, 2026, status data published Nov 20, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited